Document Detail

Educational paper: Retinopathy of prematurity.
MedLine Citation:
PMID:  22052209     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: Retinopathy of prematurity is an important cause of ocular morbidity and blindness in children. With better understanding of the pathogenesis, screening and treatment guidelines have changed over time and are unit specific.
Ingele Casteels; Catherine Cassiman; Joachim Van Calster; Karel Allegaert
Related Documents :
8266899 - Morbidity, mortality and coronavirus antigen in previously coronavirus free kittens pla...
11392589 - Preterm premature rupture of membranes is not an independent risk factor for neonatal m...
6362709 - The fetal prognosis in pemphigoid gestationis (herpes gestationis).
195759 - Intractable diarrhoea of infancy.
21890289 - Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal b...
15937809 - Neonatal short bowel syndrome: a cohort study.
15449089 - Post-shunt ascites in infants with optic chiasmal hypothalamic astrocytoma: role of ven...
1604999 - A microanalytical study on human auditory ossicles in normal and pathological conditions.
11270829 - Transient hyponatriemia complicated by seizures after endoscopic third ventriculostomy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2011-11-04
Journal Detail:
Title:  European journal of pediatrics     Volume:  171     ISSN:  1432-1076     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-05-22     Completed Date:  2012-10-17     Revised Date:  2014-07-31    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  887-93     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiogenesis Inhibitors / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Infant, Newborn
Infant, Premature
Lasers, Semiconductor / therapeutic use
Neonatal Screening
Retinopathy of Prematurity* / classification,  diagnosis,  etiology,  therapy
Risk Factors
Reg. No./Substance:
0/Angiogenesis Inhibitors; 0/Antibodies, Monoclonal, Humanized; 2S9ZZM9Q9V/bevacizumab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluating ring-tailed lemurs (Lemur catta) from southwestern Madagascar for a genetic population bo...
Next Document:  Public program crowd-out of private coverage.